You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
  1. EVENTS - 25-11-2019

    Kedrion alongside IPOPI at the IPIC Congress in Madrid

    The importance of early diagnosis and the most recent innovations in the treatment of PID patients were the focus

    read more 
  2. EVENTS - 15-11-2019

    Kedrion keeps Hemophilia therapy debate flowing in Latin America

    A recent CLAHT Congress symposium restates current and future role of replacement therapy

    read more 
  3. EVENTS - 30-09-2019

    Kedrion reaffirms its commitment for the global eradication of Rh disease

    A worldwide initiative for maternal and fetal health launches in Florence, Italy

    read more 
  4. EVENTS - 17-07-2019

    Leading medical-scientific event on Hemophilia held in Trieste, Italy

    Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

    read more 

Pages

For more information please contact: pressoffice@kedrion.com